• Je něco špatně v tomto záznamu ?

Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients

H. Hribkova, O. Svoboda, E. Bartecku, J. Zelinkova, J. Horinkova, L. Lacinova, M. Piskacek, B. Lipovy, I. Provaznik, JC. Glover, T. Kasparek, YM. Sun

. 2022 ; 16 (-) : 830757. [pub] 20220223

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22009945

The cellular pathology of schizophrenia and the potential of antipsychotics to target underlying neuronal dysfunctions are still largely unknown. We employed glutamatergic neurons derived from induced pluripotent stem cells (iPSC) obtained from schizophrenia patients with known histories of response to clozapine and healthy controls to decipher the mechanisms of action of clozapine, spanning from molecular (transcriptomic profiling) and cellular (electrophysiology) levels to observed clinical effects in living patients. Glutamatergic neurons derived from schizophrenia patients exhibited deficits in intrinsic electrophysiological properties, synaptic function and network activity. Deficits in K+ and Na+ currents, network behavior, and glutamatergic synaptic signaling were restored by clozapine treatment, but only in neurons from clozapine-responsive patients. Moreover, neurons from clozapine-responsive patients exhibited a reciprocal dysregulation of gene expression, particularly related to glutamatergic and downstream signaling, which was reversed by clozapine treatment. Only neurons from clozapine responders showed return to normal function and transcriptomic profile. Our results underscore the importance of K+ and Na+ channels and glutamatergic synaptic signaling in the pathogenesis of schizophrenia and demonstrate that clozapine might act by normalizing perturbances in this signaling pathway. To our knowledge this is the first study to demonstrate that schizophrenia iPSC-derived neurons exhibit a response phenotype correlated with clinical response to an antipsychotic. This opens a new avenue in the search for an effective treatment agent tailored to the needs of individual patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22009945
003      
CZ-PrNML
005      
20220425131631.0
007      
ta
008      
220420s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fncel.2022.830757 $2 doi
035    __
$a (PubMed)35281293
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hribkova, Hana $u Department of Biology, Masaryk University, Brno, Czechia
245    10
$a Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients / $c H. Hribkova, O. Svoboda, E. Bartecku, J. Zelinkova, J. Horinkova, L. Lacinova, M. Piskacek, B. Lipovy, I. Provaznik, JC. Glover, T. Kasparek, YM. Sun
520    9_
$a The cellular pathology of schizophrenia and the potential of antipsychotics to target underlying neuronal dysfunctions are still largely unknown. We employed glutamatergic neurons derived from induced pluripotent stem cells (iPSC) obtained from schizophrenia patients with known histories of response to clozapine and healthy controls to decipher the mechanisms of action of clozapine, spanning from molecular (transcriptomic profiling) and cellular (electrophysiology) levels to observed clinical effects in living patients. Glutamatergic neurons derived from schizophrenia patients exhibited deficits in intrinsic electrophysiological properties, synaptic function and network activity. Deficits in K+ and Na+ currents, network behavior, and glutamatergic synaptic signaling were restored by clozapine treatment, but only in neurons from clozapine-responsive patients. Moreover, neurons from clozapine-responsive patients exhibited a reciprocal dysregulation of gene expression, particularly related to glutamatergic and downstream signaling, which was reversed by clozapine treatment. Only neurons from clozapine responders showed return to normal function and transcriptomic profile. Our results underscore the importance of K+ and Na+ channels and glutamatergic synaptic signaling in the pathogenesis of schizophrenia and demonstrate that clozapine might act by normalizing perturbances in this signaling pathway. To our knowledge this is the first study to demonstrate that schizophrenia iPSC-derived neurons exhibit a response phenotype correlated with clinical response to an antipsychotic. This opens a new avenue in the search for an effective treatment agent tailored to the needs of individual patients.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Svoboda, Ondrej $u Department of Biomedical Engineering, Faculty of Electrical Engineering and Communication, Brno University of Technology, Brno, Czechia
700    1_
$a Bartecku, Elis $u Department of Psychiatry, Faculty of Medicine and University Hospital Brno, Brno, Czechia
700    1_
$a Zelinkova, Jana $u Department of Biology, Masaryk University, Brno, Czechia
700    1_
$a Horinkova, Jana $u Department of Psychiatry, Faculty of Medicine and University Hospital Brno, Brno, Czechia
700    1_
$a Lacinova, Lubica $u Center of Bioscience, Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences, Bratislava, Slovakia
700    1_
$a Piskacek, Martin $u Department of Pathological Physiology, Masaryk University, Brno, Czechia
700    1_
$a Lipovy, Bretislav $u Department of Burns and Plastic Surgery, Faculty of Medicine and University Hospital Brno, Brno, Czechia
700    1_
$a Provaznik, Ivo $u Department of Biomedical Engineering, Faculty of Electrical Engineering and Communication, Brno University of Technology, Brno, Czechia $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Glover, Joel C $u Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway $u Norwegian Center for Stem Cell Research, Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway
700    1_
$a Kasparek, Tomas $u Department of Psychiatry, Faculty of Medicine and University Hospital Brno, Brno, Czechia
700    1_
$a Sun, Yuh-Man $u Department of Biology, Masaryk University, Brno, Czechia
773    0_
$w MED00163312 $t Frontiers in cellular neuroscience $x 1662-5102 $g Roč. 16, č. - (2022), s. 830757
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35281293 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220420 $b ABA008
991    __
$a 20220425131629 $b ABA008
999    __
$a ind $b bmc $g 1784445 $s 1161143
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 16 $c - $d 830757 $e 20220223 $i 1662-5102 $m Frontiers in cellular neuroscience $n Front Cell Neurosci $x MED00163312
LZP    __
$a Pubmed-20220420

Najít záznam

Citační ukazatele

Možnosti archivace